Present status of study on reversion of anti-leukemic multidrug resistance

Xiao-mei Hu; Cheng-shan Deng; Rou Ma

doi:10.1007/BF02934384

Your Location：

Home >

Browse articles >

Present status of study on reversion of anti-leukemic multidrug resistance

Updated：2021-08-27

- Present status of study on reversion of anti-leukemic multidrug resistance
- Chinese Journal of Integrative Medicine Vol. 7, Issue 4, Pages: 307-311(2001)
- Affiliations：
  
  Xiyuan Hospital Affiliated to China Academy of TCM, National TCM Therapeutic Center of Hematopathy,Beijing
- Author bio：
- Funds：
- DOI：10.1007/BF02934384
  CLC：
- Published：2001，
Scan for full text
Hu, Xm., Deng, Cs. & Ma, R. Present status of study on reversion of anti-leukemic multidrug resistance., CJIM 7, 307–311 (2001). https://doi.org/10.1007/BF02934384

Xiao-mei Hu, Cheng-shan Deng, Rou Ma. Present status of study on reversion of anti-leukemic multidrug resistance. [J]. Chinese Journal of Integrative Medicine 7(4):307-311(2001)
Hu, Xm., Deng, Cs. & Ma, R. Present status of study on reversion of anti-leukemic multidrug resistance., CJIM 7, 307–311 (2001). https://doi.org/10.1007/BF02934384 DOI：

Xiao-mei Hu, Cheng-shan Deng, Rou Ma. Present status of study on reversion of anti-leukemic multidrug resistance. [J]. Chinese Journal of Integrative Medicine 7(4):307-311(2001) DOI： 10.1007/BF02934384.

摘要

Abstract

关键词

Granulocyte Colony Stimulate FactorDrug Resistance CellTetrandrineArsenic OxideHuman Mammary Cancer

Keywords

Granulocyte Colony Stimulate FactorDrug Resistance CellTetrandrineArsenic OxideHuman Mammary Cancer

references

meng HT, lin XJ, lin MF. Experimental study on effect of CsA in reversing multidrug resistance of the sensitivity of acute leukemic cell. Chin J Hematol 1996; 17 (6): 319–320.

meng HT, lin XJ, lin MF. Influence of CsA on drug accumulation and excretion in K562/DOX cells. Chin J Hematol 1997; 18(5): 254–256.

tang JM, huang RW, li MQ, et al. Effect of CsA on Vm26 in enhancing the apoptosis induction in HL-60 cells. Chin J Hematol 1999;20(l):44–45.

zhao CT, bian SG, yang CZ, et al. A case of acute myelocytic leukemia with multidrug resistance reversed by CsA. Chin J Hematol 1995; 16(8): 347–349.

li XM, wu JX, zhang LS, et al. Clinical study on multidrug resistance reversion of CsA in recurrent intractable leukemia. Chin J Hematol 1997;18(2): 73–75.

liu LH, liu FQ, yang CZ, et al. Study on multidrug resistance reversion of IL-2 and IFN-α in leukemic cells. Chin J Hematol 1997;18(12): 646–648.

an JF, chen JM, li XZ, et al. Regulatory effect of G- CSF on P-gp expression in acute myelocytic leukemia. Chin J Hematol 1998; 19(2): 98–99.

an JF, chen JM, li XZ, et al. Regulatory effect of G- CSF on primary mdr-1/P-gp expression in acute myelocytic leukemic cell. Chin J Hematol 1998; 19(7): 342–345.

wang JC, wang QY, chen XH, et al. Study on effect of rhIL-3 in enhancing the sensitivity of acute myelocytic leukemic cells to rubidomycin. Chin J Hematol 1999;20(1): 30–32.

zhang XH, ge XY, wang C, et al. Influences of IL-3, G-CSF and GM-CSF on toxicity of Ara-C cells. Leukemia 1999;8(2): 97–98.

zhang XZ, chen YX, wang XH, et al. Experimental study on effect of umbilic blood plasma in enhancing anti-leukemic effect of Ara-C. Chin J Hematol 1999; 20(5): 229–231.

fu JR, li CR, yang XQ, et al. Study on multidrug resistance reversion of recombined human interleukin 4 in HL-60/VCR cells. Chin J Hematol 2000; 21 (2): 94–95.

hu B, zuo DP, yang CZ. Progress of study on applying antisense technique in reversing drug resistance of tumor. Chin J Hematol 1997;18(2): 106–108.

cao J, hu X, pan JR, et al. Construction of MDRl antisense RNA expression plasmid and its application in studying mechanism of anti-multidrug resistance. Chin J Med 1995;75(10): 557–558.

li HF, sun GX, lu WW, et al. Primary study on drug resistance reversion in tumor cells by multidrug resistant gene antisense oligonucleotides. Chin J Hematol 1997;18(2): 76–79.

zhang FC, lin YM, jiang YZ, et al. Study on effect of antisense gene in reversing multidrug resistance of tumor cells and inducing cell apoptosis. Chin J Hematol 1997; 18(12): 627–629.

ZHANG WQ, LIU XY, LIU HY, et al. Multidrug resistance reversion of Chinese drug RI in adriamycin resistant human mammary cancer cell line MCF7 amp;dr. Pharmacol and Clin of Chin Meteria Medica 1994; (5) : 16–21.

xu WL, ao ZF, chen YX, et al. Experimental study on effect of tetrandrine in enhancing therapeutic effect of rubidomycin and vincristine. Chin J Hematol 1994; 15(5): 256–257.

chen ZT, gu ZD. Effect of Chinese herbs on fluidity of cytomembrane in mice with lymphocytic leukemia. Chin J Integr Med (Chin) 1991;11(1): 39–40.

sun HD, li YS, ma L, et al. Thirty-two cases of APL treated with Ailing No. 1 and TCM treatment by Syndrome Differentiation. Chin J Integr Med (Chin) 1992;12(2): 170–171.

tang YJ, gu ZD. Effect of Liushen Pill on anti-relapse of acute leukemia. J TCM 1993; 34(2): 110.

qiu HY. Progress of study drug on resistance of APL to retinoic acid, the mechanism and measures against it. Foreign Med (fascicle of blood transfusion and hematol) 1999;22(1): 39–41.

huang SL. Clinical observation on treatment of APL mainly with composite indigo tablet. Chin J Hematol 1995;16(1): 26–28.

zhang P, wang SY, hu LH, et al. Seventy-two cases of APL treated with AS2O3 injection. Chin J Hematol 1996;17(2): 58–60.

hu XM, ma L, hu NP, et al. Treatment of 62 cases of acute promyelocytic leukemia by Ailing No. 1. Chin J Integr Med (Chin) 1999;19(8): 473–476.

wang SY, xiao YJ, yang HF, et al. Primary study on treatment of acute promyelocytic leukemia with arsenic preparation. Leukemia 1999; 8(6): 341–342.

li JH, zhao SJ, wang SQ, et al. Observation on effect of Ailing No. 1 in treating recurrent acute promyelocytic leukemia. Leukemia 1999; 8(6): 360–361.

chen GQ, zhu J, shi XG, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (AS2O3) in the treatment of acute promyelocytic leukemi- a:As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RARα/PML protein. Blood 1996;88: 1052–1061.

tang W, chen GQ, shen ZX, et al. In vitro study on arsenic oxide inducing cell apoptosis in promyelocytic leukemia. Chin J Hematol 1997; 18(12): 623–626.

cai X, jia PM, shi XG, et al. In vitro study on arsenic oxide inducing cell apoptosis in retinoic resistance promyelocytic leukemia cells (MR-2). Chin J Hematol 1998; 19(7): 339–341.

huang XJ. Regulatory effect of apoptosis induction of AS2O3. Chin J Hematol 1999; 20(2): 258–260.

yang CZ. Progress of study on drug resistance of tumor and its counteracting. Chin J Hematol 1997 ; 18(2): 59–60.

wei HL. Multidrug resistance of tumor and the strategem against it. Foreign Med (fascicle of blood transfusion and hematol) 2000; 23(1): 28–31.

FULL TEXT LINK

More>

Views

400

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: A clinical trial

Study on effect of Chinese herbal medicine for enhancing therapeutic efficacy on refractory drug resistant leukemia

Study of Traditional Chinese Medicine in intervening vascular remodeling after percutaneous transluminal coronary angioplasty

Clinical study on effect of Yuantong Capsule in treating vascular dementia

Effect of tetrandrine on morphine induced hyperactivity and reinforcement in mice

Related Author

No data

Related Institution

Department of Dermatology, the First Affiliated Hospital, Jinan University

Department of Dermatology, Shajing People’s Hospital

The Third Affiliated Hospital, Sun Yat-sen University

Department of Tumor and Hematology, Dongzhimen Hospital of Beijing University of Chinese Medicine

Xiyuan Hospital, China Academy of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰